1097 related articles for article (PubMed ID: 8729072)
21. Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase.
Vuorinen K; Ylitalo K; Peuhkurinen K; Raatikainen P; Ala-Rämi A; Hassinen IE
Circulation; 1995 Jun; 91(11):2810-8. PubMed ID: 7758188
[TBL] [Abstract][Full Text] [Related]
22. Isoflurane preconditioning protects against ischemia-reperfusion injury partly by attenuating cytochrome c release from subsarcolemmal mitochondria in isolated rat hearts.
Qian LP; Zhu SS; Cao JL; Zeng YM
Acta Pharmacol Sin; 2005 Jul; 26(7):813-20. PubMed ID: 15960887
[TBL] [Abstract][Full Text] [Related]
23. Prevention of the ischemia-induced decrease in mitochondrial Tom20 content by ischemic preconditioning.
Boengler K; Gres P; Cabestrero A; Ruiz-Meana M; Garcia-Dorado D; Heusch G; Schulz R
J Mol Cell Cardiol; 2006 Sep; 41(3):426-30. PubMed ID: 16828795
[TBL] [Abstract][Full Text] [Related]
24. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts.
Griffiths EJ; Halestrap AP
J Mol Cell Cardiol; 1993 Dec; 25(12):1461-9. PubMed ID: 7512654
[TBL] [Abstract][Full Text] [Related]
25. Exogenous adenosine, supplied transiently during reperfusion, ameliorates depressed endogenous adenosine production in the post-ischemic rat heart.
Smolenski RT; Simmonds HA; Chambers DJ
J Mol Cell Cardiol; 1997 Jan; 29(1):333-46. PubMed ID: 9040048
[TBL] [Abstract][Full Text] [Related]
26. The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection.
Fukuda H; Luo CS; Gu X; Guo L; Digerness SB; Li J; Pike MM
J Mol Cell Cardiol; 2001 Mar; 33(3):545-60. PubMed ID: 11181022
[TBL] [Abstract][Full Text] [Related]
27. Postischemic administration of succinate reverses the impairment of oxidative phosphorylation after cardiac ischemia and reperfusion injury.
Cairns CB; Ferroggiaro AA; Walther JM; Harken AH; Banerjee A
Circulation; 1997 Nov; 96(9 Suppl):II-260-5. PubMed ID: 9386108
[TBL] [Abstract][Full Text] [Related]
28. Effects of nicorandil preconditioning on membrane dystrophin.
Shojima T; Hayashida N; Nishi A; Takagi K; Hori H; Yoshikawa K; Aoyagi S
Eur J Cardiothorac Surg; 2006 Sep; 30(3):472-9. PubMed ID: 16859916
[TBL] [Abstract][Full Text] [Related]
29. Ischemic preconditioning preserves end-ischemic ATP, enhancing functional recovery and coronary flow during reperfusion.
Kaplan LJ; Bellows CF; Blum H; Mitchell M; Whitman GJ
J Surg Res; 1994 Jul; 57(1):179-84. PubMed ID: 8041135
[TBL] [Abstract][Full Text] [Related]
30. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
Strasser R; Vogt A; Schaper W
Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of quinidine on post-ischemic contractile failure of isolated rat hearts.
Liu JX; Tanonaka K; Sanbe A; Yamamoto K; Takeo S
J Mol Cell Cardiol; 1993 Oct; 25(10):1249-63. PubMed ID: 8263956
[TBL] [Abstract][Full Text] [Related]
32. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
[TBL] [Abstract][Full Text] [Related]
33. [Energy metabolism and contractile function of the heart in diabetic cardiomyopathy: effect of ischemia and reperfusion].
Dzhavadov SA; Dzhokharidze TZ; Dzhaliashvili IV; Gel'fgat EB; Saks VA; Pogacha G
Biokhimiia; 1992 Dec; 57(12):1917-29. PubMed ID: 1294259
[TBL] [Abstract][Full Text] [Related]
34. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
[TBL] [Abstract][Full Text] [Related]
35. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat.
Kolodgie FD; Farb A; Litovsky SH; Narula J; Jeffers LA; Lee SJ; Virmani R
J Mol Cell Cardiol; 1997 Sep; 29(9):2403-14. PubMed ID: 9299364
[TBL] [Abstract][Full Text] [Related]
36. Dystrophin is a possible end-target of ischemic preconditioning against cardiomyocyte oncosis during the early phase of reperfusion.
Kyoi S; Otani H; Hamano A; Matsuhisa S; Akita Y; Fujiwara H; Hattori R; Imamura H; Kamihata H; Iwasaka T
Cardiovasc Res; 2006 May; 70(2):354-63. PubMed ID: 16466703
[TBL] [Abstract][Full Text] [Related]
37. The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion.
Jeremy RW; Ambrosio G; Pike MM; Jacobus WE; Becker LC
J Mol Cell Cardiol; 1993 Mar; 25(3):261-76. PubMed ID: 8510169
[TBL] [Abstract][Full Text] [Related]
38. Delayed ischemic preconditioning activates nuclear-encoded electron-transfer-chain gene expression in parallel with enhanced postanoxic mitochondrial respiratory recovery.
McLeod CJ; Jeyabalan AP; Minners JO; Clevenger R; Hoyt RF; Sack MN
Circulation; 2004 Aug; 110(5):534-9. PubMed ID: 15277332
[TBL] [Abstract][Full Text] [Related]
39. A role of PKC in the improvement of energy metabolism in preconditioned heart.
Yabe K; Tanonaka K; Koshimizu M; Katsuno T; Takeo S
Basic Res Cardiol; 2000 Jun; 95(3):215-27. PubMed ID: 10879623
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of riboflavin and its derivatives against ischemic reperfused damage of rat heart.
Kotegawa M; Sugiyama M; Haramaki N
Biochem Mol Biol Int; 1994 Oct; 34(4):685-91. PubMed ID: 7866293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]